Skip to main content
SpringerLink
Log in

Determination of Asbestos Exposure by Pathology and Clinical History

  • Chapter
Book cover Malignant Mesothelioma

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Spirtas R, Heineman EF, Bernstein L. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 1994;51:804–811.

    PubMed  CAS  Google Scholar 

  2. McDonald AD, McDonald JC. Malignant mesothelioma in North America. Cancer 1980;46:1650–1656.

    Article  PubMed  CAS  Google Scholar 

  3. Browne K, Wagner JC. Environmental exposure to amphibole-asbestos and mesothelioma. In: Noland RP, Langer AM, Ross M, Wicks FJ, Martin RF, eds. The Health Effects of Chrysotile Asbestos. The Canadian Mineralogist Special Publication, vol 5. Ottawa, Canada: Mineralogical Association of Canada, 2001:21–28.

    Google Scholar 

  4. Nolan RP, Langer AM. Concentration and type of asbestos fibres in air inside buildings. In: Nolan RP, Langer AM, Ross M, Wicks FJ, Martin RF, eds. The Health Effects of Chrysotile. The Canadian Mineralogist Special Publication vol 5. Ottawa, Canada: Mineralogical Association of Canada, 2001:39–51.

    Google Scholar 

  5. De Vuyst P, Karjalainen A, Dumortier P, et al. Guidelines for mineral fibre analyses in biological samples: report of the ERS working group. Eur Respir J 1998;11:1416–1426.

    Article  PubMed  Google Scholar 

  6. Hodgson J, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000;44:565–601.

    Article  PubMed  CAS  Google Scholar 

  7. Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Med 1992;34:718–721.

    PubMed  CAS  Google Scholar 

  8. Gibbs AR, Griffiths DM, Pooley FD, Jones JSP. Comparison of fibre types and size distributions in lung tissues of paraoccupational and occupational cases of malignant mesothelioma. Br J Ind Med 1990;47:621–626.

    PubMed  CAS  Google Scholar 

  9. Gibbs GW. Etiology of pleural calcification; a study of Quebec chrysotile asbestos miners and millers. Arch Environ Health 1979;34:76–83.

    PubMed  CAS  Google Scholar 

  10. Weiss W. Asbestos-related pleural plaques and lung cancer. Chest 1993;103:1854–1859.

    PubMed  CAS  Google Scholar 

  11. Stephens M, Gibbs AR, Pooley FD, Wagner JC. Asbestos induced pleural fibrosis. Thorax 1987;42:583–588.

    PubMed  CAS  Google Scholar 

  12. Gibbs AR, Stephens M, Griffiths DM, Blight BJN, Pooley FD. Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis. Br J Ind Med 1991;48:762–770.

    PubMed  CAS  Google Scholar 

  13. Doyle TC, Lawler GA. CT features of rounded atelectasis of the lung. AJR 1984;143:225–228.

    PubMed  CAS  Google Scholar 

  14. Gevenois PA, de Maertelaer V, Madani A, et al. Asbestosis, pleural plaques and diffuse pleural thickening: three distinct benign responses to asbestos exposure. Eur Respir J 1998;11:1021–1027.

    Article  PubMed  CAS  Google Scholar 

  15. De Vuyst P, Pfitzenmeyer P, Camus PH. Asbestos, ergot drugs and the pleura. Eur Respir J 1997;10:2695–2698.

    Article  PubMed  Google Scholar 

  16. Churg A, Warnock ML. Asbestos and other ferruginous bodies. Am J Pathol 1981;102:447–456.

    PubMed  CAS  Google Scholar 

  17. Churg A, Warnock ML. Asbestos fibres in the general population. Am Rev Respir Dis 1980;122:669–678.

    PubMed  CAS  Google Scholar 

  18. Whitwell F, Scott J, Grimshaw M. Relationship between occupations and asbestos fibre content of the lungs in patients with pleural mesothelioma, lung cancer and other diseases. Thorax 1977;32:377–386.

    PubMed  CAS  Google Scholar 

  19. Ashcroft T, Heppleston AG. The optical and electron microscope determination of pulmonary asbestos fibre concentrations and its relation to the human pathological reaction. J Clin Pathol 1973;26:224–234.

    PubMed  CAS  Google Scholar 

  20. Gibbs AR, Pooley FD. Analysis and interpretation of inorganic mineral particles in “lung tissues.” Thorax 1996;51:327–334.

    Article  PubMed  CAS  Google Scholar 

  21. Paris C, Galateau-Salle F, Creveuil C, et al. Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure. Eur Respir J 2002;20:1167–1173.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Histopathology, Llandough Hospital, South Glamorgan, Wales, UK

    Allen R. Gibbs TD, MBChB, FRCPath

Authors
  1. Allen R. Gibbs TD, MBChB, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Thoracic Oncology, Barbara Ann Karmanos Cancer Institute, Harper University Hospital, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  2. Wayne State University School of Medicine, Detroit, MI, 48201, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  3. Nevada Cancer Institute, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  4. Department of Internal Medicine, University of Nevada School of Medicine, Las Vegas, NV, 81935, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  5. Thoracic Oncology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, 60153, USA

    Michele Carbone MD, PhD (Professor of Pathology, Director) (Professor of Pathology, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Gibbs, A.R. (2005). Determination of Asbestos Exposure by Pathology and Clinical History. In: Pass, H.I., Vogelzang, N.J., Carbone, M. (eds) Malignant Mesothelioma. Springer, New York, NY. https://doi.org/10.1007/0-387-28274-2_16

Download citation

  • DOI: https://doi.org/10.1007/0-387-28274-2_16

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22949-2

  • Online ISBN: 978-0-387-28274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation